These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 26703815)
21. Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer? São Julião GP; Habr-Gama A; Vailati BB; Aguilar PB; Sabbaga J; Araújo SEA; Mattacheo A; Alexandre FA; Fernandez LM; Gomes DB; Gama-Rodrigues J; Perez RO Eur J Surg Oncol; 2018 Jan; 44(1):93-99. PubMed ID: 29217398 [TBL] [Abstract][Full Text] [Related]
22. The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy. Ahn DH; Wu C; Wei L; Williams TM; Wuthrick E; Abdel-Misih S; Harzman A; Husain S; Schmidt C; Goldberg RM; Bekaii-Saab T Am J Clin Oncol; 2017 Dec; 40(6):531-534. PubMed ID: 25723741 [TBL] [Abstract][Full Text] [Related]
23. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center. Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403 [TBL] [Abstract][Full Text] [Related]
24. Clinical outcome of neoadjuvant chemoradiation in locally advanced rectal cancer at a tertiary hospital. Yeung WW; Ma BB; Lee JF; Ng SS; Cheung MH; Ho WM; Tsang MW; Chu S; Lam DC; Mo FK Hong Kong Med J; 2016 Dec; 22(6):546-55. PubMed ID: 27795447 [TBL] [Abstract][Full Text] [Related]
25. Effects of neoadjuvant chemotherapy with or without intensity-modulated radiotherapy for patients with rectal cancer. He F; Yu L; Ding Y; Li ZH; Wang J; Zheng J; Chen HY; Liu S; Pang XL; Ajani JA; Wan XB Cancer Sci; 2020 Nov; 111(11):4205-4217. PubMed ID: 32860448 [TBL] [Abstract][Full Text] [Related]
26. Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer. Huang MY; Lee HH; Tsai HL; Huang CW; Yeh YS; Ma CJ; Huang CM; Chen CY; Huang JJ; Wang JY Radiat Oncol; 2018 Mar; 13(1):53. PubMed ID: 29587797 [TBL] [Abstract][Full Text] [Related]
27. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer. Meng Y; Wan L; Zhang C; Wang C; Ye F; Li S; Zou S; Cheng J; Xu K; Zhou C; Zhang H Acad Radiol; 2020 Sep; 27(9):e233-e243. PubMed ID: 31780392 [TBL] [Abstract][Full Text] [Related]
28. Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation. Probst CP; Becerra AZ; Aquina CT; Tejani MA; Wexner SD; Garcia-Aguilar J; Remzi FH; Dietz DW; Monson JR; Fleming FJ; J Am Coll Surg; 2015 Aug; 221(2):430-40. PubMed ID: 26206642 [TBL] [Abstract][Full Text] [Related]
29. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy. Koo T; Song C; Kim JS; Kim K; Chie EK; Kang SB; Lee KW; Kim JH; Jeong SY; Kim TY PLoS One; 2015; 10(9):e0138728. PubMed ID: 26381522 [TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of early complete response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy: Multicentric study of Turkish Society for Radiation Oncology Group (TROD). Kılıç D; Sert F; Görken İB; Arıcan Alıcıkuş Z; Aktürk N; Kaytan Sağlam E; Kizir A; Özkök S; Yılmaz HT; Göçen F; Yalman D Turk J Gastroenterol; 2020 May; 31(5):368-377. PubMed ID: 32519956 [TBL] [Abstract][Full Text] [Related]
31. Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy. Zhang LN; Xiao WW; Xi SY; OuYang PY; You KY; Zeng ZF; Ding PR; Zhang HZ; Pan ZZ; Xu RH; Gao YH Oncotarget; 2016 Feb; 7(5):6335-44. PubMed ID: 26695441 [TBL] [Abstract][Full Text] [Related]
32. Applicability of American Joint Committee on Cancer and College of American Pathologists Regression Grading System in Rectal Cancer. Jäger T; Neureiter D; Urbas R; Klieser E; Hitzl W; Emmanuel K; Dinnewitzer A Dis Colon Rectum; 2017 Aug; 60(8):815-826. PubMed ID: 28682967 [TBL] [Abstract][Full Text] [Related]
33. Mandard tumour regression grade, perineural invasion, circumferential resection margin and post-chemoradiation nodal status strongly predict outcome in locally advanced rectal cancer treated with preoperative chemoradiotherapy. Dhadda AS; Bessell EM; Scholefield J; Dickinson P; Zaitoun AM Clin Oncol (R Coll Radiol); 2014 Apr; 26(4):197-202. PubMed ID: 24485884 [TBL] [Abstract][Full Text] [Related]
34. Clinical implications of perineural invasion in patients with colorectal cancer. Hu G; Li L; Hu K Medicine (Baltimore); 2020 Apr; 99(17):e19860. PubMed ID: 32332645 [TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. Maru N; Ohori M; Kattan MW; Scardino PT; Wheeler TM Hum Pathol; 2001 Aug; 32(8):828-33. PubMed ID: 11521227 [TBL] [Abstract][Full Text] [Related]
36. Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer. Kim JW; Kim YB; Choi JJ; Koom WS; Kim H; Kim NK; Ahn JB; Lee I; Cho JH; Keum KC Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e577-84. PubMed ID: 22981710 [TBL] [Abstract][Full Text] [Related]
37. Adjuvant chemotherapy for the perineural invasion of colorectal cancer. Suzuki T; Suwa K; Ogawa M; Eto K; Kawahara H; Fujita T; Ikegami M; Yanaga K J Surg Res; 2015 Nov; 199(1):84-9. PubMed ID: 25935467 [TBL] [Abstract][Full Text] [Related]
38. MRI morphologic and clinicopathologic characteristics for predicting outcomes in patients with locally advanced rectal cancer. Meng Y; Wan L; Ye F; Zhang C; Zou S; Zhao X; Xu K; Zhang H; Zhou C Abdom Radiol (NY); 2019 Nov; 44(11):3652-3663. PubMed ID: 30456561 [TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy. Wen B; Zhang L; Wang C; Huang R; Peng H; Zhang T; Dong J; Xiao W; Zeng Z; Liu M; Gao Y Radiat Oncol; 2015 Jun; 10():124. PubMed ID: 26040453 [TBL] [Abstract][Full Text] [Related]
40. Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series. Sastre J; Serrano JJ; Fernández C; Ramirez C; Ortega L; García-Paredes B; Corona J; Alfonso R; Córdoba S; Díaz-Rubio E Clin Colorectal Cancer; 2016 Jun; 15(2):128-34. PubMed ID: 26385572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]